Iterum Therapeutics plc (NASDAQ:ITRM), a pharmaceutical company with a market capitalization of $53.43 million, has reported a regulatory compliance issue with the Nasdaq Stock Market. According to ...

The portfolio is defined by a persistent overweighting in biotech stocks and an underweighting in pharmaceutical stocks relative to the Russell 3000 Health Care Index. It has historically ...

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), a pharmaceutical company with a market capitalization of $72.6 million, has ...

It operates through the following segments: Consumer Health, Pharmaceutical, and MedTech. The Consumer Health segment includes products focused on personal healthcare used in the Skin Health ...

Agostini’s Ltd has changed its name to Agostini Ltd. The name change follows a meeting of its shareholders today.

Ad hoc announcement pursuant to Art. 53 LR The updated invitation to the bondholder meeting - scheduled for February 25, 2025 - sets out the terms of the resolutions to be voted uponUnaudited Financia ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

PureHealth Holding PJSC ("PureHealth" or "the Group") (ADX Symbol: PUREHEALTH), the largest healthcare group in the Middle ...

As an additional blunt force to your wallet Trump signed an executive order voiding the Biden bill lowering prescription drug ...

Zelenirstat, a cancer-fighting pill made in Alberta, may have the power to save lives — but millions more in clinical trial funding and donations are needed to make it a reality.

PureHealth achieved a 58% year-on-year increase in revenue to AED 25.8 billion in FY-2024, reflecting a combination of strong ...